Mesoblast Limited vs Wheaton Precious Metals Corp — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Wheaton Precious Metals Corp trades at $136.77 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 27.6× Mesoblast Limited's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | WPM | |
|---|---|---|
Market Cap | $2.21B | $60.94B |
Sector | Technology | Basic Materials |
52-Week High | $20.96 | $165.72 |
52-Week Low | $12.88 | $91.02 |
Enterprise Value | $2.21B | $62.82B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →